Shares ofArcutis Biotherapeutics, Inc. (NASDAQ:ARQT) rose sharply in today's pre-market trading after the company reported better-than-expected first-quarter financial results.
Arcutis Biotherapeutics reported quarterly earnings of 32 cents per share which beat the analyst consensus estimate of losses of 73 cents. Quarterly sales clocked in at $49.57 million, beating the analyst consensus estimate of $14.68 million, according to data from Benzinga Pro.
Arcutis Biotherapeutics shares jumped 29% to $10.49 in the pre-market trading session.
Here are some other stocks moving in pre-market trading.
Gainers
- Faraday Future Intelligent Electric Inc. (NASDAQ:FFIE) gained 113.8% to $0.6098 in pre-market trading after...
Login or create a forever free account to read this news
Sign up/Log in